New Publication from Xiang Lab in Cell Mol Immunol
"Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44+CD62Lhigh IL-7R+ CTLs with up- and downregulation of anti- and pro-apoptosis genes"
Authors: Wang R, Freywald A, Chen Y, Xu J, Tan X, Xiang J.
Cell Mol Immunol. 2014 Sep 8 PMID: 25195511
The paper can be accessed here: http://www.ncbi.nlm.nih.gov/pubmed/25195511